Mechanical thrombectomy for acute ischemic stroke (temporary stroke) is a minimally invasive endovascular procedure to remove blood clots from larger vessels in the brain.
Who is it recommended for?
Mechanical thrombectomy is indicated for patients who:
1. Had an Acute ischemic stroke due to LAO
2. Has failed intravenous thrombolysis
3. Have temporarily or permanent disabilities with the the below mentioned.
Complications:
a. Paralysis or loss of movement in muscles
b. Difficulty when talking or swallowing
c. Memory loss or difficulty in processing thoughts, reasoning or making decisions/judgements
d. Pain or numbness in affected parts
e. Change in moods, behaviour and self-care ability.
However, consulting physicians and surgeons decide if Mechanical thrombectomy for Acute Ischemic (temporary) Stroke is a suitable option for the patient. The decision is made based on various factors, such as age, severity of the stroke, time and test results. Eligible patients should receive intravenous alteplase without delay even if mechanical thrombectomy is being considered.
Recovery after Mechanical thrombectomy:
Recovery of the patient depends on:
1. Overall condition
2. Severity of the stroke
3. Severity of the symptoms
Patients are seen usually walking within 24 hours.of the procedure, but if the injury is severe then doctors recommend a couple of days rest with physiotherapy and rehabilitation.
Benefits of Mechanical thrombectomy for acute ischemic stroke are:
1. Greater Efficacy
2. Cost Effective
3. Larger Treatment window (up to 24 hours)
4. Short Hospital stay and rehabilitation
Mechanical thrombectomy for acute ischemic stroke (temporary stroke) is a minimally invasive endovascular procedure to remove blood clots from larger vessels in the brain.
Mechanical thrombectomy for acute ischemic stroke (temporary stroke) is a minimally invasive endovascular procedure to remove blood clots from larger vessels in the brain.
Who is it recommended for?
Mechanical thrombectomy is indicated for patients who:
1. Had an Acute ischemic stroke due to LAO
2. Has failed intravenous thrombolysis
3. Have temporarily or permanent disabilities with the the below mentioned.
Complications:
a. Paralysis or loss of movement in muscles
b. Difficulty when talking or swallowing
c. Memory loss or difficulty in processing thoughts, reasoning or making decisions/judgements
d. Pain or numbness in affected parts
e. Change in moods, behaviour and self-care ability.
However, consulting physicians and surgeons decide if Mechanical thrombectomy for Acute Ischemic (temporary) Stroke is a suitable option for the patient. The decision is made based on various factors, such as age, severity of the stroke, time and test results. Eligible patients should receive intravenous alteplase without delay even if mechanical thrombectomy is being considered.
Recovery after Mechanical thrombectomy:
Recovery of the patient depends on:
1. Overall condition
2. Severity of the stroke
3. Severity of the symptoms
Patients are seen usually walking within 24 hours.of the procedure, but if the injury is severe then doctors recommend a couple of days rest with physiotherapy and rehabilitation.
Benefits of Mechanical thrombectomy for acute ischemic stroke are:
1. Greater Efficacy
2. Cost Effective
3. Larger Treatment window (up to 24 hours)
4. Short Hospital stay and rehabilitation
Mechanical thrombectomy for acute ischemic stroke (temporary stroke) is a minimally invasive endovascular procedure to remove blood clots from larger vessels in the brain.
I am a Neurosurgeon with advanced training in Interventional vascular Neurosurgery(FINR) from Zurich, Switzerland, and FMINS-Fellowship in minimally invasive and Endoscopic Neurosurgery from Germany.
I am presently working in Columbia asia hospitals, Bangalore.
My areas of interest are Vascular Neurosurgery, Stroke specialist, interventional neuroradiology,
Various coronary physiological measurements can be made in the cardiac catheterization laboratory using sensor-tipped guidewires; they include the measurement of poststenotic absolute coronary flow reserve, the relative coronary flow reserve, and the pressure-derived fractional flow reserve of the myocardium. Ambiguity regarding abnormal microcirculation has been reduced or eliminated with measurements of relative coronary flow reserve and fractional flow reserve. The role of microvascular flow impairment can be separately determined with coronary flow velocity reserve measurements. In addition to lesion assessment before and after intervention, emerging applications of coronary physiology include the determination of physiological responses to new pharmacological agents, such as glycoprotein IIb/IIIa blockers, in patients with acute myocardial infarction. Measurements of coronary physiology in the catheterization laboratory provide objective data that complement angiography for clinical decision-making
"Revolutionizing Stroke Care: Endovascular Therapy and Neuro Intervention in Acute Ischemic Stroke with Dr. Ganesh"
🌟 Greetings, everyone! Dr. Ganesh here, and today, we're exploring a groundbreaking topic that's transforming the landscape of stroke care: Endovascular Therapy and Neuro Intervention in Acute Ischemic Stroke (AIS). Whether you're a healthcare professional, a patient, or simply intrigued by medical advancements, this discussion is tailored for you.
I am a Neurosurgeon with advanced training in Interventional vascular Neurosurgery(FINR) from Zurich, Switzerland, and FMINS-Fellowship in minimally invasive and Endoscopic Neurosurgery from Germany.
I am presently working in Columbia asia hospitals, Bangalore.
My areas of interest are Vascular Neurosurgery, Stroke specialist, interventional neuroradiology,
Various coronary physiological measurements can be made in the cardiac catheterization laboratory using sensor-tipped guidewires; they include the measurement of poststenotic absolute coronary flow reserve, the relative coronary flow reserve, and the pressure-derived fractional flow reserve of the myocardium. Ambiguity regarding abnormal microcirculation has been reduced or eliminated with measurements of relative coronary flow reserve and fractional flow reserve. The role of microvascular flow impairment can be separately determined with coronary flow velocity reserve measurements. In addition to lesion assessment before and after intervention, emerging applications of coronary physiology include the determination of physiological responses to new pharmacological agents, such as glycoprotein IIb/IIIa blockers, in patients with acute myocardial infarction. Measurements of coronary physiology in the catheterization laboratory provide objective data that complement angiography for clinical decision-making
"Revolutionizing Stroke Care: Endovascular Therapy and Neuro Intervention in Acute Ischemic Stroke with Dr. Ganesh"
🌟 Greetings, everyone! Dr. Ganesh here, and today, we're exploring a groundbreaking topic that's transforming the landscape of stroke care: Endovascular Therapy and Neuro Intervention in Acute Ischemic Stroke (AIS). Whether you're a healthcare professional, a patient, or simply intrigued by medical advancements, this discussion is tailored for you.
Stroke a rare complication in Post PCI patientPRAVEEN GUPTA
In this ppt i am going to describe about one patient who develop acute stroke after PCI in our hospital. Also i am going to discuss how to diagnose, manage and treat such patient, risk factor associated with stroke after PCI.
Terapi Endovaskuler, Standar Baru Manajemen Stroke Iskemik Akut? Ersifa Fatimah
Konon, plenary pertama International Stroke Conference (ISC) 2015 yang digelar di Nashville, Tennessee bulan Februari lalu merupakan sesi ISC terseru selama beberapa tahun terakhir. Sebagaimana diberitakan dalam Medscape (Hughes, 2015), para presenter terpaksa memberi jeda beberapa saat untuk menyambut applause dari audiens. Suatu kejadian langka dalam partemuan saintifik. Adalah MR CLEAN, ESCAPE, EXTEND-IA, dan SWIFT PRIME yang menjadi topik hangat lantaran keempat studi ini dirilis dengan hasil yang positif dramatis hingga diprediksi bakal menjadikan terapi endovascular sebagai standar baru dalam manajemen stroke iskemik akut. Sehebat apakah 4 studi yang “menyejarah” dalam tatalaksana stroke iskemik akut ini? Bagaimana bila studi-studi ini diadopsi dan diaplikasikan dalam praktik sehari-hari di sentra kita?
Note: Esai ini ditulis saat SWIFT PRIME fulltext belum published (akhir Maret-awal April 2015). Update & beberapa revisi dibuat menjelang presentasi tanggal 18 Mei 2015.
Thrombolysis and thrombectomy for acute ischaemic strokeHan Naung Tun
Reperfusion by intravenous thrombolysis or endovascular
mechanical thrombectomy improves functional outcomes
after stroke, but benefit for both treatment modalities is highly
time-dependent. Maximum benefit requires minimisation
of onset-to-treatment times. The safety and efficacy of IV
rtPA is established across a broad range of clinical scenarios.
Endovascular treatment now offers greatly improved outcome
among patients with poor response to IV rtPA but efficacy
has been established only in the context of highly organised
neurovascular interventional services.
Clinical and Angiographic Predictors of No-Reflow Phenomenon after Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients; Mansoura Experience
It took another 10 years, after a positive response of a different Review Board,before the first alcohol septal ablation (ASA) could be performed at the Royal Brompton Hospital in London 25 years ago.1
The very first patient, after having been informed in great length and meticulous detail about all possible risks,agreed to an experimental procedure, the outcome of which could not be defined.
She had severe left ventricular hypertrophy that created an impressive and highly
symptomatic outflow tract gradient despite pacing and drug treatment; after the ablation on June 18, 1994, she remained asymptomatic for >20 years.
Endovascular and surgical treatment of pulmonary embolism 26.11.17Ivo Petrov
Interventional treatment (thrombus fragmentation and supraselective fibrinolysis) of high and intermediate risk patients with pulmonary embolism.
Protocols of intervention, results, clinical cases provided
An Interesting Case of Stuck Mitral Valve by Clot, Post Thrombolysis Develope...Premier Publishers
Prosthetic mechanical valve thrombosis is seen in patients with inadequate anticoagulation, irregular medications, and lack of proper follow up. Thrombolysis is a good alternative to surgery in selected cases. Acute limb ischemia may one of the embolic complications that may occur post thrombolysis. Early PAG and catheter directed re- thrombolysis despite having high risk can further save patients from such serious complications and its sequalae.
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxNeurologyKota
emergence of autoimmune neuropathies and role of nodal and paranodal regions in their pathophysiology.
Peripheral neuropathies are traditionally categorized into demyelinating or axonal.
dysfunction at nodal/paranodal region key for better understanding of patients with immune mediated neuropathies.
antibodies targeting node and paranode of myelinated nerves have been increasingly detected in patients with immune mediated neuropathies.
have clinical phenotype similar common inflammatory neuropathies like Guillain Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
they respond poorly to conventional first line immunotherapies like IVIG
This presentation briefs out the approach of dementia assessment in line with consideration of recent advances. Now the pattern of assessment has evolved towards examining each individual domain rather than lobar assessment.
This presentation contains information about Dementia in Young onset. Also it describes the etiologies, clinical feature of common YOD & their management.
Entrapment Syndromes of Lower Limb.pptxNeurologyKota
This presentation contains information about the various Entrapment syndromes of Lower limb in descending order of topography. It also contains information about etiology, clinical features and management of each of these entrapment syndromes with special emphasis on electrodiagnostic confirmation.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Intraarterial thrombolysis in stroke
1. Intra arterial therapy in acute
ischemic stroke
Dr. Bhavin J Patel
DM neurology resident
GMC, Kota
2.
3. Introduction
Acute ischemic stroke (AIS) is the leading
cause of adult disability and the third
leading cause of death in the United
States, yet until recently it was considered
to be untreatable.
4. Intra arterial therapy
Intra arterial thrombolysis
Multimodal approach:- IV+IA thrombolysis
IA thrombolysis + IV GP 2b/3a
antagonist
Mechanical thrombectomy
7. IA thrombolysis :- theoretical
advantage
Higher concentrations delivered to clot
Gentle mechanical disruption of clot
Precise imaging of anatomy and
collateral pattern
Exact degree and timing of
recanalization
10. Conclusions:- for ant.
circulation
The lack of recanalization is linked to
poor outcome
Better rate of recanalizaton: 70% vs
34%
Likely better outcome than iv tPA
Larger therapeutic window
Can be given post operative
Haemorrhage rate 7 to 10%
Drawback:- technique, time to
intiation, dose variation
11. Conclusions:- vertebrobasilar
circ.
No satisfactory studies
IAT only life saving therapy available
Benefit in mortality and morbidity after
recanalization
Upto 24 hr of detoriation or 48 hr of
onset
Less benefit in coma, quadriparesis
and large infarct pre treatment.
19. only rely on imaging parameters ?
Beyond 12 hrs? Possible?
20. 6 to 16 hours
after a patient
was
last known to be
well
endovascular
therapy plus
standard medical
therapy resulted
in better
functional
outcomes than
standard medical
therapy alone
21. known to be well 6 to
24 hours earlier and
who had a mismatch
between clinical
deficit and infarct,
outcomes for
disability at 90 days
were better with
thrombectomy plus
standard care than
with standard care
alone.
23. Conclusion
Under the imaging guidance, the
future of acute ischemic treatment is
likely to have longer windows and
multiple treatment modalities used
together:
IV thrombolysis+
IA thrombectomy+
Anticoagulants+
hypothermia+
neuronal protecting agents
24. Identify patient early
The earlier, the more option we have
Using imaging to identify those outside
window
Identify patient ea
The earlier, the m
Using imaging to
the window
Stronger and bett
be used in evolvin
an even later time
27. Conclusion:-
Direct comparison with iv tPA
Provide flexibility in treatment
Appropriate selection lead to timely
and rapid reopening of occluded
vessel
29. 2) Should IV be performed
before thrombectomy in LVO
strokes ?
In favour of IV:-
Softening thrombus for thrombectomy
(less passes, less cost, shorter
procedure)
Reperfusion of persisting distal emboli
post thrombectomy !
30. 2) Should IV be performed
before thrombectomy in LVO
strokes ?
Against IV r-tPA:-
IV t-PA Cost
More symptomatic hemorrhages
within/without the infarct
Increased delay to thrombectomy (drip
and ship +++)
Proximal thrombus migration
31. Contraindications: IAT
Intracerebral hemorrhage (lobar,
subdural, intraventicular)
Subarachnoid hemorrhage
History of intracerebral hemorrhage
(ICH)
Cerebral arteriovenous malformation
or giant thrombosed cerebral
aneurysma
32. Contraindications: IAT
Computed tomographic evidence of
>1/3 middle cerebral artery (MCA)
territory acute infarct or large ischemic
core on perfusion imaging
Absence of ischemic penumbra
Uncontrolled hypertension >185/110
mmHg
Unknown stroke duration
33. Contraindications: IAT
Thrombocytopenia <100,000
Bleeding diathesis
International normalized ratio >1.7 (if
fibrinolysis is planned)
History of Alzheimer’s disease or
amyloid angiopathy
34. complications
Distal embolization in a different
territory
Intramural arterial dissection
Arterial perforation
Access-site complications leading to
intervention
35. limitations
Recanalization efficacy
Recanalizaton not equated with
reperfusion
Intracerebral haemorrhage
Reperfusion injury or cytotoxicity
No fixed dose or definition of failure for
iv r-tPA.